oprah podcast glp 1 The | Have you or someone close to you recently lost a significant amount of weight using a GLP-1 medication and found that it's affected your Myths About GLP-1 Medications

The CNS GLP- 1 receptors are not necessary for the physiological regulation of blood glucose levels by endogenous GLP- 1 or the pharmacological control of glucose homeostasis that depends on GLP- 1 receptors, although further research is needed to investigate the possible role of GLP- 1 receptors expressed outside the beta cell, including within the enteric and peripheral nervous systems, in improving beta cell function through enteral glucose mediation [70, 84]

From a common disease standpoint it makes sense, he said

Clinicians avoid prescribing GLP-1 agonists for people with a history of pancreatitis and stop treatment if pancreatitis occurs during use

Within a structured, monitored program, clinicians sometimes combine agents that work through different mechanisms a stimulant appetite suppressant and a GLP-1 agonist act on entirely separate pathways, so the rationale for layering them is coherent

GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management

The higher the GLP-1 RA dose, the more pronounced these effects